Article Text

PDF
▾ Misoprostol for co-prescription with NSAIDs

Abstract

Misoprostol (Cytotec - Searle) is the first prostaglandin analogue licenced for oral use in Britain. It is intended for the treatment of gastric and duodenal ulcers, including those induced by non-steroidal anti-inflammatory drugs (NSAIDs). It is the first drug to be licensed for ‘prophylaxis of NSAID-induced ulcers’. How effective is it and when should it be used?

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.